An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer
Clinical trial NCT03690141 · TERMINATED
Trial details
- NCT number
- NCT03690141
- Sponsor
- Effector Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-27
- Primary completion
- 2020-04-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.